共 50 条
- [31] Tumor-stimulated CD107a/b expression identifies tumor specific CD4+T cells in tumor-infiltrating lymphocyte (TIL) culture from a melanoma patientJOURNAL OF IMMUNOLOGY, 2006, 176 : S271 - S271Moudgil, TarsemHaley, DanielJensen, Shawn M.Poehlein, Christian H.Hu, Hong-MingSmith, John W., IIUrba, Walter J.Walker, Edwin S.Fox, Bernard A.
- [32] Lifileucel (LN-144), a cryopreserved autologous tumor infiltrating lymphocyte (TIL) therapy in patients with advanced (unresectable or metastatic) melanoma: durable duration of response at 28 month follow up.CANCER RESEARCH, 2021, 81 (13)Chesney, Jason AlanLarkin, James M.Kirkwood, John M.Weber, Jeffrey S.Khushalani, Nikhil I.Lewis, KarlMedina, Theresa M.Kluger, Harriet M.Thomas, Sajeve S.Domingo-Musibay, EvidioOlah, JuditWhitman, Eric D.Martin-Algarra, SalvadorCorrie, Philippa G.Lutzky, JoseHamid, OmidShi, WenWu, XiaoJagasia, MadanFinckenstein, Friedrich GrafFardis, MariaSarnaik, Amod A.
- [33] Establishment and Characterization of a Panel of Human Uveal Melanoma Xenografts Derived from Primary and/or Metastatic Tumors (vol 16, pg 2352, 2010)CLINICAL CANCER RESEARCH, 2010, 16 (14)Nemati, F.Sastre-Garau, X.Laurent, C.Couturier, J.Mariani, P.Desjardins, L.Piperno-Neumann, S.Lantz, O.Asselain, B.Plancher, C.Robert, D.Peguillet, IDonnadieu, M. H.Dahmani, A.Bessard, M. A.Gentien, D.Reyes, C.Saule, S.Barillot, E.Roman-Roman, S.Decaudin, D.
- [34] AKT inhibition during ex vivo tumor-infiltrating lymphocyte (TIL) expansion enhances cytokine production and function while increasing the population of less differentiated (CD39-CD69-) CD8+T-cellsANNALS OF ONCOLOGY, 2021, 32 : S1395 - S1395Cubas, R.Yuhas, A.Machin, M.Zhang, Y.
- [35] Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell TherapyJOURNAL OF IMMUNOTHERAPY, 2024, 47 (09) : 361 - 368Einstein, David J.Halbert, BrianDenize, ThomasMatar, SayedWest, Destiny J.Gupta, MamtaAndrianopoulos, EmanuelleSeery, VirginiaHerman, CourtneyOnimus, KennethWells, AdrianBunch, BrittanySignoretti, SabinaNatarajan, ArvindVeerapathran, AnandMcDermott, David F.
- [36] Generation and Characterization of Ex Vivo Expanded Tumor-Infiltrating Lymphocytes from Renal Cell Carcinoma Tumors for Adoptive Cell TherapyONCOLOGIST, 2024, 29 : S26 - S27Einstein, David
- [37] A relevant panel of human uveal melanoma xenografts directly established from primary and/or metastatic patient's tumor for pharmacological preclinical assaysEJC SUPPLEMENTS, 2008, 6 (12): : 24 - 24Nemati, F.Sastre, X.Couturier, J.Mariani, P.Piperno-Neumann, S.Desjardins, L.Lantz, O.Dahiani, A.Arrufat, S.Poupon, M. F.Decaudin, D.
- [38] TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in combination with pembrolizumab vs pembrolizumab alone in treatment-naive unresectable or metastatic melanomaCANCER RESEARCH, 2024, 84 (07)Thomas, SajeveHong, Young KiSamhouri, YazanLarkin, JamesOlson, David J.In, Gino K.Atkinson, VictoriaLammers, PhilipFurness, Andrew J.Martin-Liberal, JuanTerheyden, PatrickPoklepovic, Andrew S.Nguyen, Ryan H.Peretz, IditButler, MarcusKhattak, AdnanSpain, LaviniaGaughan, E. M.Wilson, MelissaDubay, John W.Williams, AnjaGoff, StephanieDoolittle, Gary C.Chesney, JasonFinckenstein, Friedrich GrafChou, JeffreyWu, XiaoSulur, GiriShi, WenHaanen, John
- [39] EFFECTS OF CYTOKINES ON INVITRO GROWTH OF TUMOR-INFILTRATING LYMPHOCYTES OBTAINED FROM HUMAN PRIMARY AND METASTATIC LIVER-TUMORSCANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 32 (05) : 280 - 288SHIMIZU, YIWATSUKI, SHERBERMAN, RBWHITESIDE, TL
- [40] Ex vivo expansion and characterization of Tumor Infiltrating Lymphocytes from two distinct cancers -: a common platform for future adoptive cell transfer therapyAPMIS, 2008, 116 (05) : 431 - 432Junker, N.Andersen, M. H.Straten, P.Svane, I. M.